Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to
their capacity for local engrafting and differentiating into multiple tissue types. However …

Mesenchymal stem cells (MSC) exhibit a high self‐renewal capacity, multilineage
differentiation potential and immunomodulatory properties. This set of exceptional features …

Originally isolated from bone marrow, mesenchymal stromal cells (MSCs) have since been
obtained from various fetal and post-natal tissues and are the focus of an increasing number …

Mesenchymal stem cells (MSCs) are broadly distributed cells that retain postnatal capacity
for self-renewal and multilineage differentiation. MSCs evade immune detection, secrete an …

Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in
supporting cellular therapy. Bone marrow (BM) was the first source reported to contain …

Mesenchymal stromal cells (MSC) have gained immense attraction in regenerative
medicine, tissue engineering, and immunotherapy. This is based on their differentiation …

Mesenchymal stem cells (MSC s) have recently generated great interest in the fields of
regenerative medicine and immunotherapy due to their unique biologic properties. In this …

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitor cells
capable of differentiating into multiple lineages of the mesenchyme. MSCs have emerged as …

OBJECTIVE: Various preparative protocols have been proposed for the acquisition and
cultivation of mesenchymal stem cells (MSC). Whereas surface antigen markers have failed …

Mesenchymal stem cells (MSCs) are clinically useful due to their capacity for self-renewal,
their immunomodulatory properties and tissue regenerative potential. These cells can be …